Fluoxetine Protects Retinal Ischemic Damage in Mice

Area of Science:

• Ophthalmology
• Neuroscience
• Pharmacology

Background:

• Acute retinal damage poses a significant threat to vision.
• Ischemia/reperfusion (I/R) injury is a common cause of acute retinal damage.
• Neuroprotective strategies are crucial for preserving retinal function.

Purpose of the Study:

• To investigate the neuroprotective potential of topical ocular fluoxetine (FLX).
• To evaluate FLX's efficacy in a mouse model of acute retinal damage.
• To assess FLX's impact on retinal ganglion cell (RGC) function and inflammation.

Main Methods:

• Acute retinal damage induced via ocular ischemia/reperfusion (I/R) in C57BL/6J mice.
• Assessment of RGC function using pattern electroretinogram (PERG).
• Quantification of retinal inflammatory markers (IL-6, TNF-α, Iba-1, IL-1β, S100β) via Digital Droplet PCR.

Main Results:

• Topical FLX significantly improved PERG amplitude and reduced latency in I/R-injured retinas.
• I/R injury led to a significant increase in retinal inflammatory markers.
• FLX treatment significantly attenuated the expression of these pro-inflammatory markers.

Conclusions:

• Topical FLX demonstrates significant neuroprotective effects against RGC damage.
• FLX treatment effectively preserves retinal function and reduces inflammation post-I/R injury.
• Further research is warranted to explore FLX as a therapeutic agent for retinal degenerative diseases.